Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New antiretroviral drugs part I: PIs.

AIDS clinical care - 1 May 1999

Murphy R L

Abstract excerpt

This first installment of a two-part article on new antiretroviral drugs in development provides information on seven new protease inhibitors (PIs). The results of in vitro and in vivo trials are provided. Researchers hope these drugs will be more potent and effective, have favorable resistance profiles, and be better tolerated by patients. Featured PIs include ABT 378, tipranavir, and DMP 450.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to CD4 Lymphocyte Count
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Mutation

Share to Viral Load

Source

Identifiers

PMID: 11367101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New antiretroviral drugs part I: PIs.PMID 11367101Read ↗

Current and Novel Inhibitors of HIV ProteaseSemantic proximity Read ↗

HIV-1 protease inhibitors: effects on HIV-2 replication and resistanceSemantic proximity Read ↗

HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistanceSemantic proximity Read ↗

Pharmacological advances in anti‐retroviral therapy for human immunodeficiency virus‐1 infection: A comprehensive reviewSemantic proximity Read ↗

New nucleoside reverse transcriptase inhibitors for the treatment of HIV infectionsSemantic proximity Read ↗

Recent developments in HIV protease inhibitor therapy.Semantic proximity Read ↗

Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic optionsSemantic proximity Read ↗

Antiretroviral drugsSemantic proximity Read ↗

Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.Semantic proximity Read ↗

New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infectionsSemantic proximity Read ↗

Clinical update: adverse effects of antiretroviral therapySemantic proximity Read ↗

Anti-HIV agents. Monotherapy studies--points to consider.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.